Peptide Therapeutics Market by Route of Administration and Geography - Forecast and Analysis 2022-2026

The peptide therapeutics market share is expected to increase to USD 23.36 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 12.52%.

This peptide therapeutics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers peptide therapeutics market segmentation by route of administration (parenteral, oral, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The peptide therapeutics market report also offers information on several market vendors, including Almac Group Ltd., AmbioPharm Inc., Amgen Inc., AstraZeneca Plc, Bachem AG, Bristol Myers Squibb Co., Corden Pharma International GmbH, Eli Lilly and Co., Ever Pharma, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Ipsen Pharma, Lonza Group Ltd., Novartis AG, Novo Nordisk AS, PeptiDream Inc., Pfizer Inc., PolyPeptide Group, Sanofi, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Worg pharma among others.

What will the Peptide Therapeutics Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Peptide Therapeutics Market Size for the Forecast Period and Other Important Statistics

 

Peptide Therapeutics Market: Key Drivers, Trends, and Challenges

The increasing prevalence of infectious diseases is notably driving the peptide therapeutics market growth, although factors such as complexities in manufacturing, storage conditions, distribution policies, and high cost may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the peptide therapeutics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Peptide Therapeutics Market Driver

One of the key factors driving the global peptide therapeutics industry growth is the increasing prevalence of infectious diseases. The outbreak of infectious disease has increased due to changing lifestyles, which result in reduced immunity. The pattern of infection incidence has also been changing with the evolution of drug-resistant pathogens. HIV/AIDS is a leading cause of death in many countries, however, it has decreased in many countries since 2010. For instance, the prevalence of meningococcal disease, which is caused by the bacterium Neisseria, meningitides, was decreased, owing to the meningococcal vaccines, which were licensed and made available in August 2020 in the US. According to the CDC data, of 2021, annually, almost 4,100 cases and 500 deaths occur due to meningococcal disease in the US. Thus, a rise in the incidence and prevalence of infectious diseases due to climate change is expected to drive market growth during the forecast period.

Key Peptide Therapeutics Market Trend

Collaboration for research and development is one of the key peptide therapeutics market trends that is expected to impact the industry positively in the forecast period. Companies are entering into strategic alliances to overcome technological and research challenges. For instance, AstraZeneca entered into a collaboration agreement with Bicycle Therapeutics for the development of novel peptide-based therapies using Bicycles, which is Bicycle Therapeutics novel peptide technology for the treatment of respiratory, cardiovascular, and various metabolic disorders. AstraZeneca agreed to pay USD 1 billion to Bicycle Therapeutics. The pharmaceutical companies such as Novo Nordisk, Zealand Pharma, and Zydus Cadila sponsor various research programs with the Peptide Therapeutics Foundation, a not-for-profit organization focusing on the development of peptides for the treatment of various indications, which will further support the market growth in the coming years.

Key Peptide Therapeutics Market Challenge

One of the key challenges to the global peptide therapeutics industry growth is the complexities in manufacturing, storage conditions, distribution policies, and high cost. The manufacturing process of proteins is very complex and time-consuming, as it involves fermentation, clarification, separation, and purification. The purification process is lengthy, and the risk of contamination is high as the drug is produced in a biological medium. All through the process, proper temperature, pressure, and pH should be maintained. For instance, Eprex, a biosimilar, was found to be structurally unidentical to Amgen EPOGEN as small differences were found in the hydrodynamic structure and the degree of alfa helicity, which affected the stability of the product. In addition, these processes require large investments in biotechnology and sterile production facilities. Insulin treatment also suffers from poor storage and distribution policies. Inadequate distribution policies and lack of a centralized supply chain lead to intra-country variability in pricing. Such factors may impede the market growth in the forecast period.

This peptide therapeutics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global peptide therapeutics market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the peptide therapeutics market during the forecast period.

Who are the Major Peptide Therapeutics Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

• Almac Group Ltd.
• AmbioPharm Inc.
• Amgen Inc.
• AstraZeneca Plc
• Bachem AG
• Bristol Myers Squibb Co.
• Corden Pharma International GmbH
• Eli Lilly and Co.
• Ever Pharma
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Ipsen Pharma
• Lonza Group Ltd.
• Novartis AG
• Novo Nordisk AS
• PeptiDream Inc.
• Pfizer Inc.
• PolyPeptide Group
• Sanofi
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
• Worg pharma

 

This statistical study of the peptide therapeutics market encompasses successful business strategies deployed by the key vendors. The peptide therapeutics market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market.

Product Insights and News

• Amgen Inc. - The unified segment focuses on discovering, developing, manufacturing, and delivering innovative human therapeutics. 
• Amgen Inc. - The company offers Therapeutic proteins which are extensively used for the treatment of cancer, HIV, and other diseases. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The peptide therapeutics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Peptide Therapeutics Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the peptide therapeutics market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Peptide Therapeutics Market?

For more insights on the market share of various regions Request for a FREE sample now!

39% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for peptide therapeutics in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).

The significant increase in the sales of peptide therapeutics and the rising number of biosimilars will facilitate the peptide therapeutics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The COVID-19 pandemic spread widely across North America, especially in the US, in 2020. However, in Q1 2021, the initiation of vaccination programs led to the resumption of business operations, including the supply chain of peptide therapeutics. The regional peptide therapeutics market witnessed positive growth in 2021 due to the increase in the demand for peptide therapeutics to mitigate the threat of COVID-19. Due to this, the regional peptide therapeutics market will grow during the forecast period

What are the Revenue-generating Route of Administration Segments in the Peptide Therapeutics Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The peptide therapeutics market share growth by the parenteral segment will be significant during the forecast period. Most of the major peptide drugs that are currently approved in the market are administered through the parenteral route. The popularity of parenteral RoA for peptide therapeutics is largely due to the rapid absorption of drugs and, thereby, the avoidance of drug loss through first-pass metabolism. Such factors will drive the segment growth in the coming years.

This report provides an accurate prediction of the contribution of all the segments to the growth of the peptide therapeutics market size and actionable market insights on post COVID-19 impact on each segment.

 

Peptide Therapeutics Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 12.52%
Market growth 2022-2026	$ 23.36 billion
Market structure	Fragmented
YoY growth (%)	8.8
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 39%
Key consumer countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Almac Group Ltd., AmbioPharm Inc., Amgen Inc., AstraZeneca Plc, Bachem AG, Bristol Myers Squibb Co., Corden Pharma International GmbH, Eli Lilly and Co., Ever Pharma, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Ipsen Pharma, Lonza Group Ltd., Novartis AG, Novo Nordisk AS, PeptiDream Inc., Pfizer Inc., PolyPeptide Group, Sanofi, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Worg pharma
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Peptide Therapeutics Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive peptide therapeutics market growth during the next five years
• Precise estimation of the peptide therapeutics market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the peptide therapeutics industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of peptide therapeutics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch